InvAscent exits Synergia life Sciences with over 11-fold returns after sale to Novozymes

By Ranjani Raghavan

  • 13 Dec 2021
Premium
Credit: Pexels

Healthcare-focussed private equity (PE) firm InvAscent has exited Synergia Life Sciences Pvt Ltd, with over 11-fold returns after...

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Become a Premium member
Already a member? Click here to log in.